I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78%
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

InDex Pharmaceuticals Holding AB
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InDex Pharmaceuticals Holding AB
Additional Paid In Capital Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
MOB

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Additional Paid In Capital
kr5.5B
CAGR 3-Years
85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Additional Paid In Capital
kr3.3B
CAGR 3-Years
22%
CAGR 5-Years
24%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Additional Paid In Capital
kr6.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Additional Paid In Capital
kr690.2m
CAGR 3-Years
0%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Additional Paid In Capital
kr921.3m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InDex Pharmaceuticals Holding AB's Additional Paid In Capital?
Additional Paid In Capital
5.5B SEK

Based on the financial report for Jun 30, 2024, InDex Pharmaceuticals Holding AB's Additional Paid In Capital amounts to 5.5B SEK.

What is InDex Pharmaceuticals Holding AB's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 3Y
85%

Over the last year, the Additional Paid In Capital growth was 536%. The average annual Additional Paid In Capital growth rates for InDex Pharmaceuticals Holding AB have been 85% over the past three years .

Back to Top